Multiple Docetaxel Retreatments Without Prednisone for Metastatic Castration-Resistant Prostate Cancer in the Docetaxel-Only Era: Effects on PSA Kinetics and Survival
Version 2 2021-05-18, 16:24Version 2 2021-05-18, 16:24
Version 1 2021-05-18, 16:23Version 1 2021-05-18, 16:23
media
posted on 2021-05-18, 16:24authored byAdis Rapid Journals on behalf of:, Agnieszka Maj-Hes, Tibor Szarvas, Sabina Sevcenco, Gero Kramer
Article full
text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).